CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation have?
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation has 793 citations in the OpenAlex counts ScholarIQ stores.
When was CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation published?
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation has 2017 year in the ScholarIQ index.
What is the open-access status of CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation?
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation has bronze oa status in the ScholarIQ index.
What is the DOI of CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation?
The DOI for CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation is on the source record.
What is the PMID of CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation?
The PMID for CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation is on the source record.
What is the OpenAlex record for CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation?
The OpenAlex for CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation is on the source record.